Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Azurity Pharmaceuticals, Inc

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Azurity Pharmaceuticals, Inc with status Current. The shortage was first posted on Apr 10, 2020.

Shortage details

Status
Current
Company
Azurity Pharmaceuticals, Inc
Package NDC
52536-126-08
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08)
Initial Posting
Apr 10, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.